P
Profusa, Inc. (PFSA)
NGM – Real vaqt narxi. Valyuta: USD
0.45
-0.03 (-7.09%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.45
+0.00 (0.58%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
0.45
-0.03 (-7.09%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.45
+0.00 (0.58%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Profusa, Inc. Qo'shma Shtatlarda shaxsiy va tibbiy foydalanish uchun tana uchun bio-muhandislik sensorlarini ishlab chiqadi, ular klinik darajadagi ma'lumotlarni aniqlash va doimiy ravishda uzatish uchun mo'ljallangan. U tomir kasalliklari, surunkali yaralar va rekonstruktiv jarrohlikda shikastlangan to'qimalarni nazorat qilish uchun Lumee Oxygen platformasini taklif etadi. Kompaniya Lumee Glucose platformasini tadqiq qiladi va ishlab chiqadi, bu esa interstitsial suyuqlikdagi glyukoza darajasini nazorat qilish uchun mo'ljallangan. Profusa, Inc. Kaliforniyaning Berkeley shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ben Chung-Bin Hwang Ph.D. | CEO & Chairman |
| Mr. David Icke | Head of Digital Health Business |
| Mr. Fred S. Knechtel | Chief Financial Officer |
| Mr. Phil Constantinou | Head of Software & Data Science |
| Mr. Sean Givens | Head of Government Business |
| Mr. William McMillan | Co-founder, Chief Scientific Officer & Head of Research |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-12 | PRE 14A | ea0289795-01.htm |
| 2026-05-08 | 8-K | ea0289597-8k_profusa.htm |
| 2026-05-01 | S-1/A | ea0288583-s1a1_profusa.htm |
| 2026-04-29 | 8-K | ea0288135-8k_profusa.htm |
| 2026-04-28 | S-1 | ea0287086-s1_profusa.htm |
| 2026-04-27 | 8-K | ea0287686-8k_profusa.htm |
| 2026-04-24 | 8-K | ea0287591-8k_profusa.htm |
| 2026-04-15 | 10-K | ea0282813-10k_profusa.htm |
| 2026-04-06 | 8-K | ea0285151-8k_profusa.htm |
| 2026-04-01 | NT 10-K | ea0284416-nt10k_profusa.htm |